首页 文献索引 SCI期刊 AI助手
期刊目录筛选

期刊名:Expert review of pharmacoeconomics & outcomes research

缩写:EXPERT REV PHARM OUT

ISSN:1473-7167

e-ISSN:1744-8379

IF/分区:2.2/Q3

文章目录 更多期刊信息

共收录本刊相关文章索引2196
Clinical Trial Case Reports Meta-Analysis RCT Review Systematic Review
Classical Article Case Reports Clinical Study Clinical Trial Clinical Trial Protocol Comment Comparative Study Editorial Guideline Letter Meta-Analysis Multicenter Study Observational Study Randomized Controlled Trial Review Systematic Review
Panagiotis Petrou Panagiotis Petrou
Introduction: End-stage renal disease is associated with significant comorbidity and mortality. Among its implications, hyperphosphatemia constitutes a consistent and independent risk factor. The use of benchmark treatmen...
Shoroq M Altawalbeh,Rawan Abu-Su&#x;Ud,Qais Alefan et al. Shoroq M Altawalbeh et al.
Background: Intensive Care Unit (ICU) medication costs contribute to a large portion of the total ICU costs. Evaluating ICU drug expenditures is essential for optimal resource use especially in countries with limited resources. Considering ...
Kyriakos Souliotis,Christina Golna,Chara Kani et al. Kyriakos Souliotis et al.
Objectives: The economic crisis in Greece has triggered an extensive public debate about the use of generic drugs (generics). Despite their cost-saving potential, generic market penetration remains very low. This raises questions on awarene...
Sara Malo,María José Rabanaque,Valentina Orlando et al. Sara Malo et al.
Background: Antihypertensive drugs play a crucial role in reducing cardiovascular morbidity and mortality. Variability in prescribing patterns constitutes a major challenge for current healthcare systems. This study aimed to compare pattern...
Arijeet Sensharma,K Robin Yabroff Arijeet Sensharma
Poor prescription drug adherence is common, jeopardizing the benefits of treatment and increasing the costs of health care in the United States. A frequently reported barrier to adherence is patient out-of-pocket (OOP) costs. Areas Covered:...
Kasem S Akhras,Alawi A Alsheikh-Ali,Samer Kabbani Kasem S Akhras
Real-world evidence (RWE) is increasingly being used in coverage, reimbursement and formulary decisions for medicines globally. Areas covered: The Middle East (ME) region is significantly behind in generating and using RWE in health policy ...
Terese Geraghty,Guido LaPorta Terese Geraghty
Introduction: Diabetic foot ulcer (DFU) prevalence is as high as 25% and 40-80% of DFUs become infected (DFI). About 20% of infected ulcers will spread to bone causing diabetic foot osteomyelitis (DFO). DFU costs Medicare...
Mandy Gutknecht,Rabea Reinert,Matthias Augustin Mandy Gutknecht
Introduction: Atopic dermatitis (AD) is a common chronic, pruritic inflammatory skin disease. It is associated with a high personal burden of illness and economic consequences. Since AD can occur at any age, and many trea...
Ramon Schaefer,Michael Schlander Ramon Schaefer
Objectives: Our study explores whether, and how, different methodological choices are associated with different health technology assessment (HTA) outcomes. We focus on the Federal Joint Committee (Gemeinsamer Bundesausschuss, G-BA) in Germ...
Pei Wang,Gordon G Liu,Min-Woo Jo et al. Pei Wang et al.
Objectives: To compare the time trade-off (TTO) utility values of EQ-5D-5L health states elicited from different general populations in Asia. Methods: We analyzed the TTO data from seven Asian EQ-5D-5L valuation studies in which utility val...